# Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity

> **NCT06340451** · NA · RECRUITING · sponsor: **Pacira Pharmaceuticals, Inc** · enrollment: 132 (estimated)

## Conditions studied

- Spasticity, Cerebral or Spinal Condition

## Interventions

- **DEVICE:** iovera° system
- **DEVICE:** sham iovera° system treatment

## Key facts

- **NCT ID:** NCT06340451
- **Lead sponsor:** Pacira Pharmaceuticals, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-11
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 132 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06340451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06340451, "Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06340451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*